Review



brain glioma cell u87 mg luc2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC brain glioma cell u87 mg luc2
    Relative expression of miR-124 in <t>U87</t> brain glioma stem cells after transfection. The RT-qPCR results showed that the relative expression of miR-124 in cells of miR-124 mimic group was significantly higher than that of miR-124 inhibitor and miR-control groups, while miR-124 inhibitor group was lower than miR-control group. *P<0.05.
    Brain Glioma Cell U87 Mg Luc2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 10427 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brain+glioma+cell+u87+mg+luc2/pmc06755475-29-0-8?v=ATCC
    Average 99 stars, based on 10427 article reviews
    brain glioma cell u87 mg luc2 - by Bioz Stars, 2026-08
    99/100 stars

    Images

    1) Product Images from "miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression"

    Article Title: miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression

    Journal: Experimental and Therapeutic Medicine

    doi: 10.3892/etm.2019.7914

    Relative expression of miR-124 in U87 brain glioma stem cells after transfection. The RT-qPCR results showed that the relative expression of miR-124 in cells of miR-124 mimic group was significantly higher than that of miR-124 inhibitor and miR-control groups, while miR-124 inhibitor group was lower than miR-control group. *P<0.05.
    Figure Legend Snippet: Relative expression of miR-124 in U87 brain glioma stem cells after transfection. The RT-qPCR results showed that the relative expression of miR-124 in cells of miR-124 mimic group was significantly higher than that of miR-124 inhibitor and miR-control groups, while miR-124 inhibitor group was lower than miR-control group. *P<0.05.

    Techniques Used: Expressing, Transfection, Quantitative RT-PCR, Control

    Expression of Nogo-A and NgR protein in U87 brain glioma stem cells.
    Figure Legend Snippet: Expression of Nogo-A and NgR protein in U87 brain glioma stem cells.

    Techniques Used: Expressing

    (A) Expressions level of Nogo-A protein in U87 brain glioma stem cells after transfection. The relative expression of Nogo-A protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. (B) Expression level of NgR protein in U87 brain glioma stem cells after transfection. The relative expression of NgR protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.
    Figure Legend Snippet: (A) Expressions level of Nogo-A protein in U87 brain glioma stem cells after transfection. The relative expression of Nogo-A protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. (B) Expression level of NgR protein in U87 brain glioma stem cells after transfection. The relative expression of NgR protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.

    Techniques Used: Transfection, Expressing, Control

    Detection results of U87 brain glioma stem cells by MTT proliferation in vitro . The absorbance values of the cells in the miR-124 mimic and miR-control groups were significantly lower than those in the miR-124 inhibitor group at each time point, while the miR-124 mimic group was significantly lower than miR-control group. *P<0.05, compared with miR-control group; # P<0.05, compared with miR-124 inhibitor group.
    Figure Legend Snippet: Detection results of U87 brain glioma stem cells by MTT proliferation in vitro . The absorbance values of the cells in the miR-124 mimic and miR-control groups were significantly lower than those in the miR-124 inhibitor group at each time point, while the miR-124 mimic group was significantly lower than miR-control group. *P<0.05, compared with miR-control group; # P<0.05, compared with miR-124 inhibitor group.

    Techniques Used: In Vitro, Control

    Detection results of CD133 + U87 brain glioma stem cells. The level of CD133 + cells in miR-124 mimic group was significantly lower than that in miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.
    Figure Legend Snippet: Detection results of CD133 + U87 brain glioma stem cells. The level of CD133 + cells in miR-124 mimic group was significantly lower than that in miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.

    Techniques Used: Control



    Similar Products

    brain glioma cell u87 mg luc2  (ATCC)
    99
    ATCC brain glioma cell u87 mg luc2
    Relative expression of miR-124 in <t>U87</t> brain glioma stem cells after transfection. The RT-qPCR results showed that the relative expression of miR-124 in cells of miR-124 mimic group was significantly higher than that of miR-124 inhibitor and miR-control groups, while miR-124 inhibitor group was lower than miR-control group. *P<0.05.
    Brain Glioma Cell U87 Mg Luc2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brain+glioma+cell+u87+mg+luc2/pmc06755475-29-0-8?v=ATCC
    Average 99 stars, based on 1 article reviews
    brain glioma cell u87 mg luc2 - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Relative expression of miR-124 in U87 brain glioma stem cells after transfection. The RT-qPCR results showed that the relative expression of miR-124 in cells of miR-124 mimic group was significantly higher than that of miR-124 inhibitor and miR-control groups, while miR-124 inhibitor group was lower than miR-control group. *P<0.05.

    Journal: Experimental and Therapeutic Medicine

    Article Title: miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression

    doi: 10.3892/etm.2019.7914

    Figure Lengend Snippet: Relative expression of miR-124 in U87 brain glioma stem cells after transfection. The RT-qPCR results showed that the relative expression of miR-124 in cells of miR-124 mimic group was significantly higher than that of miR-124 inhibitor and miR-control groups, while miR-124 inhibitor group was lower than miR-control group. *P<0.05.

    Article Snippet: Brain glioma cell U87 MG-Luc2 was purchased from ATCC (ATCCHTB-14-LUC2), hereinafter referred to as U87 cells and has been authenticated by STR profiling (Beijing Microread Genetics Co., Ltd.).

    Techniques: Expressing, Transfection, Quantitative RT-PCR, Control

    Expression of Nogo-A and NgR protein in U87 brain glioma stem cells.

    Journal: Experimental and Therapeutic Medicine

    Article Title: miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression

    doi: 10.3892/etm.2019.7914

    Figure Lengend Snippet: Expression of Nogo-A and NgR protein in U87 brain glioma stem cells.

    Article Snippet: Brain glioma cell U87 MG-Luc2 was purchased from ATCC (ATCCHTB-14-LUC2), hereinafter referred to as U87 cells and has been authenticated by STR profiling (Beijing Microread Genetics Co., Ltd.).

    Techniques: Expressing

    (A) Expressions level of Nogo-A protein in U87 brain glioma stem cells after transfection. The relative expression of Nogo-A protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. (B) Expression level of NgR protein in U87 brain glioma stem cells after transfection. The relative expression of NgR protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.

    Journal: Experimental and Therapeutic Medicine

    Article Title: miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression

    doi: 10.3892/etm.2019.7914

    Figure Lengend Snippet: (A) Expressions level of Nogo-A protein in U87 brain glioma stem cells after transfection. The relative expression of Nogo-A protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. (B) Expression level of NgR protein in U87 brain glioma stem cells after transfection. The relative expression of NgR protein in cells of miR-124 mimic group was significantly lower than that of miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.

    Article Snippet: Brain glioma cell U87 MG-Luc2 was purchased from ATCC (ATCCHTB-14-LUC2), hereinafter referred to as U87 cells and has been authenticated by STR profiling (Beijing Microread Genetics Co., Ltd.).

    Techniques: Transfection, Expressing, Control

    Detection results of U87 brain glioma stem cells by MTT proliferation in vitro . The absorbance values of the cells in the miR-124 mimic and miR-control groups were significantly lower than those in the miR-124 inhibitor group at each time point, while the miR-124 mimic group was significantly lower than miR-control group. *P<0.05, compared with miR-control group; # P<0.05, compared with miR-124 inhibitor group.

    Journal: Experimental and Therapeutic Medicine

    Article Title: miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression

    doi: 10.3892/etm.2019.7914

    Figure Lengend Snippet: Detection results of U87 brain glioma stem cells by MTT proliferation in vitro . The absorbance values of the cells in the miR-124 mimic and miR-control groups were significantly lower than those in the miR-124 inhibitor group at each time point, while the miR-124 mimic group was significantly lower than miR-control group. *P<0.05, compared with miR-control group; # P<0.05, compared with miR-124 inhibitor group.

    Article Snippet: Brain glioma cell U87 MG-Luc2 was purchased from ATCC (ATCCHTB-14-LUC2), hereinafter referred to as U87 cells and has been authenticated by STR profiling (Beijing Microread Genetics Co., Ltd.).

    Techniques: In Vitro, Control

    Detection results of CD133 + U87 brain glioma stem cells. The level of CD133 + cells in miR-124 mimic group was significantly lower than that in miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.

    Journal: Experimental and Therapeutic Medicine

    Article Title: miR-124 participates in the proliferation and differentiation of brain glioma stem cells through regulating Nogo/NgR expression

    doi: 10.3892/etm.2019.7914

    Figure Lengend Snippet: Detection results of CD133 + U87 brain glioma stem cells. The level of CD133 + cells in miR-124 mimic group was significantly lower than that in miR-124 inhibitor and miR-control groups, while the miR-124 inhibitor group was higher than miR-control group. *P<0.05.

    Article Snippet: Brain glioma cell U87 MG-Luc2 was purchased from ATCC (ATCCHTB-14-LUC2), hereinafter referred to as U87 cells and has been authenticated by STR profiling (Beijing Microread Genetics Co., Ltd.).

    Techniques: Control